Percutaneous coronary intervention (PCI) is a non-surgical procedure utilized to treat coronary artery disease. A balloon catheter and coronary stents are used to remove the plaque and treat narrowing of blood vessels. In a PCI procedure, a coronary guidewire is used to direct the balloon catheter to the site of plaque in the coronary artery. A balloon catheter is thereafter inserted into the coronary artery of the heart and inflated at the site of the plaque. Generally, a stent is placed at that site to mitigate the risk of restenosis at the treatment site. Global percutaneous coronary intervention devices market is expected to grow in the forecast period owing to the rise in the incidence of the heart diseases, diabetes, and coronary artery disease. Further, development of advanced technologies for PCI procedures leads to the growth of the market. 

This report studies the market for various devices used in PCI procedures and consists of latest analysis of the global percutaneous coronary intervention devices market through extensive primary and secondary research. A comprehensive understanding of the global market is provided in the report based on quantitative and qualitative research. This report aids the market stakeholders to make informed initiatives in the global percutaneous coronary intervention devices market. 

For the analysis, the global percutaneous coronary intervention devices market is categorized based on device type, usage areas, and geographical demarcation. On the basis of device type, the global percutaneous coronary intervention devices market is categorized into coronary stents, PTCA catheters, and coronary guidewires. On the basis of usage areas, the global percutaneous coronary intervention devices market is categorized into hospitals, ambulatory surgical centers, and catheterization labs. Analysis of global percutaneous coronary intervention devices market is performed in terms of market size for the period 2019-2029 considering 2020 as the base year and 2021-2029 as forecast period. CAGRS of each aforementioned segment is calculated for the forecast period.

On the basis of geographical demarcation, the market size of the global percutaneous coronary intervention devices market is presented for the period 2019-2029 and CAGRs are calculated for the forecast period. Further, geographical regions are analyzed by sub-segmenting them in terms of device type, end-user, and constituent countries. 

Major qualitative market assessment factors are incorporated in the report including key market insights, market trends and dynamics, product launches and opportunities. Competitive landscape of major players is provided in a graphical format based on market share, product portfolio, and improvement opportunities. This report also constitutes Porter’s five forces model for the proper understanding of the global percutaneous coronary intervention devices market. Major players profiled in this report include Abbott Laboratories, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Biosensors International Group, Getinge AB, Johnson & Johnson, Medtronic plc, St. Jude Medical and Terumo Corporation.

Percutaneous coronary intervention procedure is performed to treat coronary artery disease by removing the plaque from the coronary arteries. Coronary guidewires are used to direct the PTCA catheters to the site of plaque and thereafter catheters are employed for plaque removal. This is followed by stent placement at the site of plaque to prevent restenosis. In terms of market value, PTCA catheters segment leads the global percutaneous coronary intervention devices market for the year 2020 due to increased adoption in PCI procedures over conventional treatment methods; non-invasive and safer approach of PCI mainly contributes to this shift. In addition, technological advancements in the nature and material of stents will make this segment to grow at the fastest CAGR. Greater prices of stents and their incumbent role in prevention of restenosis mainly drive the growth of this segment.

Percutaneous coronary intervention (PCI) procedures are adopted across the world for the treatment of coronary heart disease. PCI is a minimally invasive procedure and thereby potentially reduces the risk of post-treatment complications and infections. In terms of market value, hospitals lead the global percutaneous coronary intervention devices market for the year 2020 due to the availability of the skilled professionals required for the PCI procedure. Furthermore, availability of favorable reimbursements in hospitals and devices that aid in minimally invasive techniques such as robotic devices favors the prominent position of hospitals segment. However, with the increase in the number of cases for PCI procedures, the population is turning towards the catheterization labs for the treatment due to quick turnaround time.

Based on geographical regions, the global percutaneous coronary intervention devices market is segmented into North America, Latin America, Asia Pacific, Europe, and Middle East and Africa. 

As per the research, North America dominated the global percutaneous coronary intervention devices market in the year 2020 and is projected retain its lead in the market throughout forecast period. Adoption of PCI procedures, improved healthcare services and high incidence of coronary artery disease in the region contributes to its dominance. The global percutaneous coronary intervention devices market in North America is expected to further grow due to supportive government initiatives and favorable reimbursement policies. According to the CDC, the coronary artery disease is the most common type of heart disease killing over 370,000 individuals annually. Further, Asia Pacific is anticipated to experience fastest market growth during the forecast years. This regional growth is anticipated due to increasing prevalence of heart diseases, and rising healthcare facilities along with awareness of general population towards heart diseases.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Percutaneous Coronary Intervention (PCI) Devices market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Percutaneous Coronary Intervention (PCI) Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Percutaneous Coronary Intervention (PCI) Devices market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Percutaneous Coronary Intervention (PCI) Devices market?
• Which is the largest regional market for Percutaneous Coronary Intervention (PCI) Devices market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Percutaneous Coronary Intervention (PCI) Devices market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Percutaneous Coronary Intervention (PCI) Devices market worldwide?